Elsevier

Cellular Signalling

Volume 80, April 2021, 109929
Cellular Signalling

Lipid rafts as platforms for sphingosine 1-phosphate metabolism and signalling

https://doi.org/10.1016/j.cellsig.2021.109929Get rights and content

Highlights

  • Association of sphingosine kinase 1 to lipid rafts is essential for its activity.

  • Membrane localization of LPPs makes them essential to regulate extracellular S1P.

  • ABC transporters not only export S1P, they are also regulated by S1P signalling.

  • S1P1 recruited to caveolin-rich domains is required for endothelial barrier function.

  • S1P receptors can cross-talk actively cross-talk with other receptor systems.

Abstract

Spontaneous segregation of cholesterol and sphingolipids as a liquid-ordered phase leads to their clustering in selected membrane areas, the lipid rafts. These specialized membrane domains enriched in gangliosides, sphingomyelin, cholesterol and selected proteins involved in signal transduction, organize and determine the function of multiprotein complexes involved in several aspects of signal transduction, thus regulating cell homeostasis. Sphingosine 1-phosphate, an important biologically active mediator, is involved in several signal transduction processes regulating a plethora of cell functions and, not only several of its downstream effectors tend to localize in lipid rafts, some of the enzymes involved in its pathway, of receptors involved in its signalling and its transporters have been often found in these membrane microdomains. Considering this, in this review we address what is currently known regarding the relationship between sphingosine 1-phosphate metabolism and signalling and plasma membrane lipid rafts.

Introduction

Sphingolipids (SLs) are minor, yet essential, components of eukaryotic cell membranes, mainly residing in the outer layer of plasma membrane with their hydrophilic head group facing out toward the extracellular milieu [1,2]. Ceramide, the simplest sphingolipid, is the backbone of all complex sphingolipids which are characterized by the presence of neutral or charged groups linked to the hydroxylated group in position 1 of the sphingoid base [3], the most common base being sphingosine (2S,3R-D-erythro-2-amino-1,3-dihydroxy-octadec-4-ene), linked to a fatty acid through an amide bond. In addition to the C18 molecular species, which is the most abundant in complex sphingolipids in mammals, homologous lipids with a different length of the carbon chain or with a saturated chain, sphinganine or 4-hydroxy-sphinganine, have been identified as minor amount components in different cells [4]. The sphingolipid class is commonly defined by the head group of the molecule, a phosphate group in ceramide 1-phosphate, phosphocholine in sphingomyelin, monosaccharides in cerebrosides, and one or more sugar residues linked with a β-glycosidic bond in complex glycosphingolipids. The latter being the most structurally diverse class of complex sphingolipids, particularly enriched in the nervous system where they are not merely structural components of the membranes, but also play other essential roles, especially in signalling [5,6]. Of the simple SLs, ceramide, ceramide 1-phosphate, sphingosine and sphingosine 1-phosphate have been shown to be involved in several cellular events, like proliferation, motility, growth, differentiation, and apoptosis. Complex glycosphingolipids (GSLs) are involved in cell physiology by acting as antigens, mediators of cell adhesion, binding agents for growth factors, and as modulators of signal transduction [5]. Gangliosides, sialic acid-containing GSLs, have been shown to be involved in the development, differentiation, and function of nervous system in vertebrates [7]. Galactosylceramide (GalCer) and sulfatide, instead, are involved in the formation and maintenance of a myelin with a correct structure [8,9], and deeply affect the survival, proliferation and differentiation of oligodendrocytes [10,11]. Glycosphingolipids are not randomly distributed along the membrane surface; moreover, they are highly segregated, together with cholesterol, in lipid domains with specialized signalling functions, organizing and determining the function of multiprotein complexes involved in several aspects of signal transduction, thus regulating the homeostasis of the brain [12]. Within the cell, they are highly asymmetrically enriched in the external leaflet of plasma membranes, with the oligosaccharide chain protruding toward the extracellular space, where the sugar residues can engage cis and trans interactions with a wide variety of cell surface and extracellular molecules [13]. The local concentration of GSLs in the membrane affects these interactions. Direct lateral interactions (cis interactions) with plasma membrane proteins are strongly favoured within a sphingolipid-enriched membrane domain [14], whereas in the case of trans interactions, it has been shown that recognition of lipid-bound oligosaccharides by soluble ligands (for example antibodies or toxins) or by complementary carbohydrates and by carbohydrate binding proteins (such as selectins or lectins) belonging to the interfacing membrane of adjacent cells is strongly affected by their degree of segregation (or dispersion) [15].

Over the past few decades, the biochemical pathways of sphingolipids metabolism and the intracellular sites of synthesis and degradation, respectively in the endoplasmic reticulum/Golgi apparatus and lysosomes, have been extensively characterized [16,17]. Sphingolipids synthesis is set in motion by a sequence of three enzyme-catalyzed reactions that, at the cytosolic leaflet of the membranes of the endoplasmic reticulum (ER), lead to the formation of ceramide starting from l-Serine and palmitoyl-CoA [1]. The use of L-Alanine or glycine instead of l-Serine leads to the synthesis of 1-deoxysphingolipids lacking the C1-OH group of canonical sphingolipids. The lack of this group renders 1-deoxySLs resistant to normal SL catabolism as the essential catabolic intermediate sphingosine-1-phosphate cannot be formed [18]. Ceramide acts as precursor of at least six different products, namely ceramide-1-phosphate, acyl-ceramide, sphingosine, sphingomyelin (SM), glucosylceramide (GlcCer), and galactosylceramide. In turn, degradation of SM and glycosphingolipids can yield ceramide. Sphingosine can be phosphorylated by two sphingosine kinases (SK1 and SK2) to produce sphingosine 1-phosphate, which, depending on where in the cell it is generated will have different fates. ER generated S1P, in fact, can be reconverted to sphingosine and then ceramide by the action of S1P phosphatases (SPP) and ceramide synthases [19]. At ER levels, S1P can also be irreversibly cleaved by S1P lyase to generate a fatty aldehyde and phosphoethanolamine [20]. S1P generated at plasma level, instead, tends to be exported from the cell more efficiently, through the action of different transporters, where it can then act as an extracellular mediator [21].

Ceramide and S1P are bioactive sphingolipids, whose levels are finely regulated, and these lipids, in turn, modulate cell growth and survival, regulating opposing signalling pathways. Increase of ceramide levels is associated with apoptosis and cell growth arrest [22], while S1P is required for optimal cell proliferation induced by growth factors [23] and suppresses ceramide-mediated apoptosis [24]. S1P has also been shown to play crucial roles in a plethora of processes such as cell migration, proliferation, differentiation, adhesion but also in stress response, inflammation and development for example during angiogenesis, cardiogenesis, limb development and neurogenesis (reviewed in [[25], [26], [27]]). Ceramide also plays critical roles in different biological processes including apoptosis, inflammation, autophagy, senescence, fatty acid oxidation and ER stress (reviewed in [28,29]). Interestingly, ceramide, also acts as a signal for the reorganization of sphingolipid-enriched plasma membrane signalling platforms [30].

These cholesterol- and sphingolipid-enriched plasma membrane signalling platforms, commonly known as lipid rafts, are involved in several biological processes. For example they play roles in cell adhesion and motility [[31], [32], [33]], endocytosis and trafficking [34], inflammatory response [35], cancer cell survival and invasion [36], neuroinflammation and pain response [37], hematopoietic stem cell retention in the bone marrow and their trafficking [38], and insulin resistance [39]. They are also involved in the pathogenesis of several neurodegenerative diseases [40].

Section snippets

Sphingosine kinases

Ceramide-derived sphingosine can either be recycled for sphingolipid synthesis or phosphorylated to generate S1P by two sphingosine kinase isoenzymes, SK1 and SK2. These enzymes have different developmental and tissue-specific expression. Moreover, while their functions are overlapping, they are also distinct due to the differences in terms of subcellular localization and of kinetic properties [41]. SK2, localizes in the plasma membrane, but also in the ER, mitochondria and nucleus.

S1P transporters and lipid rafts

Cells release S1P in the extracellular milieu through different transporters, one of which, the non-ATP dependent organic ion transporter SPNS2 (Spinster homologue 2), was recently characterized [65] and plays a role in development and organ homeostasis, in the regulation of circulating S1P, and in inflammation (reviewed in Spiegel et al. 2019 [66]). SPNS2 is localized to the plasma membrane [67], however whether or not it is enriched in plasma membrane lipid rafts has yet to be determined.

S1P receptors and lipid rafts

S1P, released from cells to the extracellular milieu through its various transporters, binds to a family of plasma membrane G-protein coupled receptors, the S1P receptors (S1P1-S1P5), triggering different biological responses, such as growth, differentiation, cell migration and trafficking [20]. S1P binds to these receptors with high affinity, with the exception of S1P4 which showed a higher affinity for phytosphingosine 1-phosphate, also known as 4D-hydroxysphinganine [82]. Nevertheless, the

S1P receptors cross talk with other receptor systems

The five S1P receptors actively cross-talk with other receptor systems. Binding of S1P to its receptors can transactivate growth factor tyrosine kinase receptors (RTKs) and stimulate growth factor and cytokine signalling cascades [105]. Activation of RTKs can, in turn, regulate SK activation [105]. Several RTKs, like the S1P receptors, are localized in cholesterol- and sphingolipid-enriched domains of the plasma membrane [106], and their localization, together with the enrichment of proteins

Conclusions

Spontaneous separation of sphingolipids, glycolipids and cholesterol in a liquid-ordered phase leads to their clustering in selected membrane areas, commonly defined as lipid rafts. Alterations in the membrane lipid composition affects the lateral organization of molecules belonging to lipid rafts. Moreover, these membrane domains seem to organize and determine the function of multiprotein complexes involved in several aspects of signal transduction, thus regulating cell homeostasis. Several

References (126)

  • Y. Zhang et al.

    Ceramide-enriched membrane domains--structure and function

    Biochim. Biophys. Acta

    (2009)
  • B.P. Head et al.

    Interaction of membrane/lipid rafts with the cytoskeleton: impact on signaling and function: membrane/lipid rafts, mediators of cytoskeletal arrangement and cell signaling

    Biochim. Biophys. Acta

    (2014)
  • A. Prinetti et al.

    A glycosphingolipid/caveolin-1 signaling complex inhibits motility of human ovarian carcinoma cells

    J. Biol. Chem.

    (2011)
  • F. Mollinedo et al.

    Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy

    J. Lipid Res.

    (2020)
  • Y.I. Miller et al.

    Lipid rafts in glial cells: role in neuroinflammation and pain processing

    J. Lipid Res.

    (2020)
  • S. Grassi et al.

    Lipid rafts and neurodegeneration: structural and functional roles in physiologic aging and neurodegenerative diseases

    J. Lipid Res.

    (2020)
  • N. Igarashi et al.

    Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis

    J. Biol. Chem.

    (2003)
  • G. Ding et al.

    Protein kinase D-mediated phosphorylation and nuclear export of sphingosine kinase 2

    J. Biol. Chem.

    (2007)
  • M. Maceyka et al.

    SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism

    J. Biol. Chem.

    (2005)
  • C.M. Sutherland et al.

    The calmodulin-binding site of sphingosine kinase and its role in agonist-dependent translocation of sphingosine kinase 1 to the plasma membrane

    J. Biol. Chem.

    (2006)
  • J.A. Hengst et al.

    Sphingosine kinase 1 localized to the plasma membrane lipid raft microdomain overcomes serum deprivation induced growth inhibition

    Arch. Biochem. Biophys.

    (2009)
  • C. Delon et al.

    Sphingosine kinase 1 is an intracellular effector of phosphatidic acid

    J. Biol. Chem.

    (2004)
  • A. Aguilar et al.

    Truth and consequences of sphingosine-1-phosphate lyase

    Adv. Biol. Regul.

    (2012)
  • D. Mechtcheriakova et al.

    FTY720-phosphate is dephosphorylated by lipid phosphate phosphatase 3

    FEBS Lett.

    (2007)
  • V.A. Sciorra et al.

    Roles for lipid phosphate phosphatases in regulation of cellular signaling

    Biochim. Biophys. Acta

    (2002)
  • Y. Zhao et al.

    Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1

    J. Biol. Chem.

    (2007)
  • L. Riboni et al.

    The role of sphingolipids in the process of signal transduction

    Prog. Lipid Res.

    (1997)
  • S. Spiegel et al.

    New insights into functions of the sphingosine-1-phosphate transporter SPNS2

    J. Lipid Res.

    (2019)
  • I.L. Aye et al.

    Transport of lipids by ABC proteins: interactions and implications for cellular toxicity, viability and function

    Chem. Biol. Interact.

    (2009)
  • A.D. Attie

    ABCA1: at the nexus of cholesterol, HDL and atherosclerosis

    Trends Biochem. Sci.

    (2007)
  • Y.D. Landry et al.

    ATP-binding cassette transporter A1 expression disrupts raft membrane microdomains through its ATPase-related functions

    J. Biol. Chem.

    (2006)
  • M. Vaidya et al.

    Regulation of ABCA1-mediated cholesterol efflux by sphingosine-1-phosphate signaling in macrophages

    J. Lipid Res.

    (2019)
  • U.J. Yun et al.

    Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition

    Biochem. Pharmacol.

    (2013)
  • L.C. Boujaoude et al.

    Cystic fibrosis transmembrane regulator regulates uptake of sphingoid base phosphates and lysophosphatidic acid: modulation of cellular activity of sphingosine 1-phosphate

    J. Biol. Chem.

    (2001)
  • A. Kihara et al.

    Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate

    Prog. Lipid Res.

    (2007)
  • G. Tigyi

    New trends in lysophospholipid research

    Biochim. Biophys. Acta

    (2013)
  • T. Hla et al.

    An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors

    J. Biol. Chem.

    (1990)
  • M.L. Oo et al.

    Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor

    J. Biol. Chem.

    (2007)
  • J.M. Ryu et al.

    Sphingosine-1-phosphate-induced Flk-1 transactivation stimulates mouse embryonic stem cell proliferation through S1P1/S1P3-dependent beta-arrestin/c-Src pathways

    Stem Cell Res.

    (2014)
  • P.A. Singleton et al.

    Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family

    J. Biol. Chem.

    (2006)
  • J. Zhao et al.

    Phosphotyrosine protein dynamics in cell membrane rafts of sphingosine-1-phosphate-stimulated human endothelium: role in barrier enhancement

    Cell. Signal.

    (2009)
  • J. Igarashi et al.

    Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction

    J. Biol. Chem.

    (2000)
  • O. Feron et al.

    The endothelial nitric-oxide synthase-caveolin regulatory cycle

    J. Biol. Chem.

    (1998)
  • H. Okamoto et al.

    EDG1 is a functional sphingosine-1-phosphate receptor that is linked via a Gi/o to multiple signaling pathways, including phospholipase C activation, Ca2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition

    J. Biol. Chem.

    (1998)
  • M.A. Marletta

    Nitric oxide synthase: aspects concerning structure and catalysis

    Cell

    (1994)
  • Y. Ephstein et al.

    Critical role of S1PR1 and integrin beta4 in HGF/c-Met-mediated increases in vascular integrity

    J. Biol. Chem.

    (2013)
  • T. Wennekes et al.

    Glycosphingolipids--nature, function, and pharmacological modulation

    Angew. Chem. Int. Ed. Eng.

    (2009)
  • T. Feizi

    Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens

    Nature

    (1985)
  • S. Lahiri et al.

    The metabolism and function of sphingolipids and glycosphingolipids

    Cell. Mol. Life Sci.

    (2007)
  • R.K. Yu et al.

    Structures, biosynthesis, and functions of gangliosides--an overview

    J. Oleo Sci.

    (2011)
  • Cited by (0)

    View full text